II. Pathophysiology

  1. Irregularly shaped Bacteria in the genus Mycoplasma, that lacks a cell wall (Penicillin resistant)
  2. Colonizes as well as causes symptomatic urogenital, oral and anal infections (sexually transmitted)
  3. Four serovars (1, 3, 6, and 14) were previously classified as Ureaplasma Urealyticum, but arre now classified as Ureaplasma Parvum
  4. May be associated with Mycoplasma Genitalium infections

IV. Labs

  1. Difficult to culture (fastidious)
  2. PCR testing availability is increasing
    1. Urethal swabs are preferred

V. Management

  1. Primary Antibiotic Regimens (adult dosing)
    1. Doxycycline 100 mg orally or IV every 12 hours for 7 to 14 days
  2. Alternative Antibiotic Regimens (adult dosing)
    1. Azithromycin 500 mg orally or IV for 10 to 14 days OR
    2. Levofloxacin 500 mg orally or IV daily for 10 to 14 days OR
    3. Moxifloxacin 400 mg orally or IV daily for 10 to 14 days

VI. Complications

  1. Infertility secondary to pelvic infections (Pelvic Inflammatory Disease)
  2. Pregnancy loss or premature labor
  3. Neonatal Sepsis, Pneumonia and Meningitis may occur
  4. Other infections include Septic Arthritis, Osteomyelitis, Pneumonia, endocarditis
  5. Hyperammonemia Syndrome (Immunocompromised patients, esp. lung transplant)
    1. Tantengco (2021) Clin Transplant 35(7):e14334 +PMID: 33948993 [PubMed]

VII. References

  1. (2024) Ureaplasma Urealyticum, Sanford Guide, accessed on IOS, 5/5/2024

Images: Related links to external sites (from Bing)

Related Studies